NRD
ZBH icon

Nebula Research & Development’s Zimmer Biomet ZBH Stock Holding History

Nebula Research & Development’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,670
Closed -$720K – 1150
2024
Q3 		$720K Buy
+6,670
New +$728K 0.09% 432

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Nebula Research & Development's ZBH Position: Q4 2024 in Review

Nebula Research & Development sold out of Zimmer Biomet (ZBH) in Q4 2024, closing a stake of 6,670 shares — an estimated $720K sold.

Nebula Research & Development first reported a position in ZBH in Q3 2024 and held it in 1 quarter. The position peaked at $720K in Q3 2024. 1,027 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

  • Nebula Research & Development reported no remaining Zimmer Biomet position as of Q4 2024 after selling out during the quarter.
  • Nebula Research & Development sold 6,670 Zimmer Biomet shares in Q4 2024, an estimated $720K.
  • Nebula Research & Development first reported a position in Zimmer Biomet in Q3 2024 and held it in 1 quarter.
  • Nebula Research & Development's Zimmer Biomet position peaked at $720K in Q3 2024.
  • 1,027 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on Nebula Research & Development's 13F filing for Q4 2024, filed 14 Feb 2025.